Global Retinitis Pigmentosa Treatment Market Report and Forecast 2024-2032

Global Retinitis Pigmentosa Treatment Market Outlook

The global retinitis pigmentosa treatment market is being driven by the growth of the retinal disorder treatment market. The global retinal disorder treatment market is expected to grow at a CAGR of 6.8% in the forecast period of 2024-2032 to reach a value of USD 24.41 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The Asia Pacific Region to Witness the Fastest Growth in the Retinitis Pigmentosa Treatment Industry, Owing to a Large Patient Pool

The market for retinitis pigmentosa is supported by the large share of the market from the North America and Europe region collectively. This can be attributed to the upcoming approvals, and a surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment. The trend is expected to persist in the forecast period as well. The Asia Pacific region is expected to accelerate at a high rate over the forecast period. The region is governed by factors, such as the rise in the adoption of new products, large patient pool, and an increase in the demand for retinitis pigmentosa treatment in the emerging economies, like India and China. The market is also positively influenced by the inflating disposable incomes, changing lifestyles, and rapid urbanisation.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Retinitis Pigmentosa Treatment: Market Segmentation

Retinitis pigmentosa treatment refers to the treatment of retinitis pigmentosa, which is a group of rare genetic disorders, which entail the breakdown and loss of cells in the retina. Common symptoms of retinitis pigmentosa include problems in seeing at night and a loss of peripheral vision.

On the basis of type, the market is divided into:

• Autosomal Recessive RP
• Autosomal Dominant RP
• X-Linked RP

Based on treatment, the industry can be segmented into:

• Drug
• Device
• Surgery

Drug is divided on the basis of type into vitamin A palmitate and acetazolamide, among others. Device is further divided on the basis of type into sunglasses, implants, and others. Surgery is divided on the basis of type into retinal transplantation and corneal neurotization, among others.

On the basis of distribution channel, the industry is categorised into:

• Hospital Retailer
• Retail Retailer
• Online

Based on end use, the industry is segmented into:

• Hospitals
• Special Clinics
• Home Care
• Ophthalmologist
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rise in the Patients Suffering from Retinitis Pigmentosa to Aid the Retinitis Pigmentosa Treatment Industry Growth

The market for retinitis pigmentosa treatment is being driven by the rise in the patients suffering from retinitis pigmentosa across the globe. The market forces, such as rich product pipeline and increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa, are expected to aid the market growth of retinitis pigmentosa treatment over the forecast period. In addition, the rise in the special designation from the supervisory to offer a treatment to the patients as soon as possible is invigorating the market growth.

Key Industry Players in the Global Retinitis Pigmentosa Treatment Market

The report gives a detailed analysis of the following key players in the global retinitis pigmentosa treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Ionis Pharmaceuticals, Inc.
• Orphagen Pharmaceuticals, Inc.
• ReNeuron Group plc
• Ocugen, Inc.
• MeiraGTx Limited.
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report